Physician profile
Vikas Mehta
NPI 1902097108
$8,339.24
in general payments reported to CMS, 2019-2025
11 companies · $2,726 in 2025
The $2,726 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $2,013 · 2021: $17.09 · 2022: $1,266 · 2023: $1,250 · 2024: $944 · 2025: $2,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,600 · Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,600.00 |
| Food and Beverage | $319.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,000.00 | 2020-2024 | |
| Janssen Global Services, LLC | $2,600.00 | 2025 | |
| Pfizer INC. | $1,250.00 | 2022 | |
| Ethicon US, LLC | $145.33 | 2024 | Harmonic |
| Med-El Corporation | $114.69 | 2024-2025 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Astrazeneca Pharmaceuticals LP | $107.20 | 2019 | |
| Atos Medical INC | $42.15 | 2020-2025 | Provox Life Home Hme |
| Checkpoint Surgical, INC | $30.55 | 2025 | Checkpoint Stimulators |
| Intuitive Surgical, INC. | $17.09 | 2021 | |
| Tactile Systems Technology INC | $16.17 | 2022 | |
| Exelixis INC. | $16.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.